Phase Iia Study Of Marrow Infiltrating Lymphocytes (Mils), An Adoptive T Cell Therapy, Alone Or In Combination With Nivolumab In Non-Small Cell Lung Cancer (Nsclc).

JOURNAL OF CLINICAL ONCOLOGY(2020)

引用 1|浏览17
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要